Nucala (Mepolizumab)

Overview
Nucala is approved by the U.S. Food and Drug Administration (FDA) as an add-on maintenance treatment for adults with chronic obstructive pulmonary disease (COPD) who have an eosinophilic phenotype (a type of…

Ohtuvayre (Ensifentrine)

Overview
Ohtuvayre is approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. It is prescribed to help manage symptoms and improve…

Perforomist (Formoterol)

Overview
Perforomist is a prescription drug first approved by the Food and Drug Administration (FDA) in 2001 for maintenance of asthma and prevention of bronchospasms in chronic obstructive pulmonary disease (COPD).… read more

Serevent Diskus (Salmeterol)

Overview
Serevent is a prescription drug approved by the Food and Drug Administration (FDA) to treat asthma and prevent bronchospasms in people age 4 and older with reversible obstructive airway problems such as chronic… read more

Spiriva (Tiotropium bromide)

Overview
Spiriva is a prescription drug approved by the Food and Drug Administration (FDA) for long-term, once-daily maintenance treatment of bronchospasms in people with chronic obstructive pulmonary disease (COPD),… read more

Stiolto Respimat (Tiotropium bromide/Olodaterol)

Overview
Stiolto Respimat is a prescription drug approved by the Food and Drug Administration (FDA) as long-term, once-daily maintenance treatment for airflow obstruction in people with chronic obstructive pulmonary… read more

Striverdi Respimat (Olodaterol)

Overview

Striverdi Respimat is a prescription drug approved by the Food and Drug Administration (FDA) in 2014 for daily maintenance of bronchospasms in chronic obstructive pulmonary disease (COPD). Striverdi Respimat… read more

Symbicort (Budesonide/Formoterol)

Overview
Symbicort is a prescription drug approved by the Food and Drug Administration (FDA) in 2006 for the treatment of asthma and 2009 for chronic obstructive pulmonary disease (COPD). Symbicort helps prevent… read more

Theo-24 (Theophylline)

Overview

Theo-24 is a prescription drug approved by the Food and Drug Administration (FDA) in 1983 to treat the symptoms of reversible airflow diseases such as asthma and chronic bronchitis. In severe cases of chronic… read more

Trelegy (Fluticasone furoate/Umeclidinium/Vilanterol)

Overview
Trelegy is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for daily maintenance treatment of chronic obstructive pulmonary disease (COPD). Trelegy helps prevent bronchospasms.… read more

Tudorza (Aclidinium bromide)

Overview
Tudorza is a prescription drug approved by the Food and Drug Administration (FDA) for maintenance treatment of bronchospasm in chronic obstructive pulmonary disease (COPD). Tudorza is not indicated for rescue… read more

Yupelri (Revefenacin)

Overview
Yupelri is approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is prescribed to help manage symptoms of COPD on a daily basis…

Zemaira (Alpha1-proteinase inhibitor [human])

Overview
Zemaira is a prescription drug approved by the Food and Drug Administration (FDA) as maintenance therapy in adults who have clinically evident emphysema due to Alpha-1 antitrypsin (AAT) deficiency, a rare… read more